PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-43.71%
Negative net income growth while MCHP stands at 22.09%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-184.74%
Both reduce yoy usage, with MCHP at -25.72%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
40.78%
AR growth of 40.78% while MCHP is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-1950.00%
Negative yoy inventory while MCHP is 574.59%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-109.32%
Both reduce yoy usage, with MCHP at -45.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
108.83%
Some yoy increase while MCHP is negative at -59.68%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-23.75%
Negative yoy CFO while MCHP is 0.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7.59%
Both yoy lines negative, with MCHP at -25.14%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-0.41%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-36.40%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-2323.33%
Both yoy lines negative, with MCHP at -25.14%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-75.64%
Negative yoy issuance while MCHP is 104.42%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.03%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.